Caisson Interventional Expands Facility in Maple Grove, Minnesota
02/07/2018
The company, which is owned by London-based LivaNova PLC, said it will invest $750,000 in the building expansion. The new jobs will be created within three years.
As an incentive, the Minnesota Department of Employment and Economic Development is supporting the project with a $359,850 grant from the Job Creation Fund. The company will receive the funding once it has met investment and hiring commitments.
“Caisson is developing a minimally invasive implantable heart valve system that has the potential to benefit millions of patients worldwide,” said DEED Commissioner Shawntera Hardy. “The company’s investment in jobs and facilities is helping to grow a medical device cluster that is one of the cornerstones of the Minnesota economy.”
LivaNova PLC last May invested $72 million to acquire a full stake in the company. Prior to the acquisition, LivaNova owned 49 percent of Caisson. Caisson, which was founded in 2012, is developing a heart valve system to replace severely diseased or damaged heart valves that don’t close tightly enough.
Most Read
-
-
On the Hunt for a Productive New Biomanufacturing Site?
Q4 2021
-
Changes in the Incentives Landscape
Q3 2021
-
Solutions for Decisively Navigating the Location Decision
Q4 2021
-
The Challenges of Renovating an Existing Facility Into a Food Plant
Q4 2021
-
First Person: Creating a Work Environment For Employee Growth and Development
Q4 2021
-
The “Great Resignation” Is Impacting Corporate Relocations
Workforce Q4 2021